Stay updated on Tislelizumab After Liver-Directed Therapy Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.

Latest updates to the Tislelizumab After Liver-Directed Therapy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a consolidated Locations section with New Jersey and New York sites, removed the separate 'New Jersey Locations' and 'New York Locations' headings, and updated the page to revision v3.3.3.SummaryDifference0.3%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the page footer; no changes to the Study Details content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedRemoved the government funding status notice from the page; the notice previously informing about potential delays due to funding and operating status updates is no longer displayed.SummaryDifference0.4%

- Check67 days agoChange DetectedThe study page content appears unchanged in its core details, with only minor layout or formatting differences visible in the screenshots.SummaryDifference0.5%

- Check95 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference3%

- Check102 days agoChange DetectedUpdated version to v3.1.0 and added contact details (phones and emails); removed the old revision tag v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Tislelizumab After Liver-Directed Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.